BWXT Selling Medical Business to Nordic Capital in Transaction Valued at up to $800 Million businesswire.com August 3, 2026 at 3:05 PM ET BWXT BWXT is selling its medical business to Nordic Capital for up to $800 million. This divestiture allows BWXT to focus on its core nuclear technology segments, which could be a strategic positive, but the immediate financial impact and future growth prospects of the remaining business are not detailed.